Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
No signal for an increase in suicidal ideation or attempts associated with GLP-1 use was seen across subgroups stratified by ...
Novo Nordisk filed suit against another semaglutide compounder on Friday, bringing its total number of cases to 50. Both Novo ...
In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...
Public employees in the plan could face premium increases of 14% for the state fund or 16% in plans for local governments. And the agency is considering possible increases in deductibles of 40% — on ...
A rapid-fire reversal from the Food and Drug Administration has injected even more uncertainty into what was already a wild ...
In win for compounders, FDA will review its decision to put Eli Lilly's tirzepatide on shortage list
In accepting the FDA’s motion, U.S. District Judge Mark Pittman put on hold a lawsuit filed by the Outsourcing Facilities ...
Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.
Met With High Demand, the Dual-Product System is Clinically Shown to Increase GLP-1 by 140% on average to Balance Hunger ...
Amgen stock dipped Monday after an analyst downgraded shares, saying the opportunity for its weight-loss drug is already ...
Researchers said the drugs don’t appear to raise the risk of suicidal thoughts or actions for young people but also urged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback